Australian woman dies of caffeine overdose after ‘unacceptable' 7-hour wait for ambulance

An Australian woman died from a caffeine overdose in April 2021 after waiting nearly seven hours for an ambulance, an inquest has heard.
Christina Lackmann, 32, from Melbourne, was feeling dizzy and numb when she called emergency services. She didn't receive any help and died alone in her bathroom hours later.
Lackmann didn't get immediate medical attention, 9News reported, because there was an 'unacceptable' delay in the ambulance arriving at her home. She was found unresponsive on her bathroom floor with her dog by her side.
A toxicology report later confirmed lethal levels of caffeine in her body, traced to 90 tablets each with 200mg caffeine that she had taken earlier in the day.
Thinking it was a case of vertigo, the emergency services operator categorised Lackmann's call as 'non-urgent' and an ambulance didn't reach her until just after 2am, nearly seven hours after she had first made the call for help.
'At 7.49pm, Christina called 000 from her mobile phone and requested an ambulance. She reported to the call-taker she felt sick, numb all over her body, and dizzy,' the coroner's file read.
'I am satisfied that Christina's death was the consequence of the ingestion of caffeine tablets, ' coroner Catherine Fitzgerald added.
'However, I am not satisfied to the requisite standard that Christina intended to take her own life, although this remains a distinct possibility.'
A paramedic was assigned to attend to the biomedical science student twice between 9.14pm and 1.46am but both times they were redirected to respond to higher-priority emergencies.
After an ambulance arrived at Lackmann's residence at 2.23am, paramedics took help from a neighbour to climb onto her balcony from an adjacent apartment. Inside, they found Lackmann dead in her bathroom.
She was found to have an exceptionally high concentration of caffeine in her blood and stomach.
According to court documents, associate professor Narendra Gunja, a specialist medical practitioner in clinical and forensic toxicology, said Lackmann likely would have received treatment sooner had she been asked about any medication she was taking during the emergency call, according to the report. 'This would likely have led to appropriate management with the use of antidote therapy and haemodialysis. If these management strategies were followed, Gunja considered it likely that Christina would have survived, even with a large caffeine overdose,' the file recorded.
'However, in the absence of information about the time Christina ingested the caffeine, or the length of time between ingestion and the making of 000 call, Gunja was not able to pinpoint a specific time at which Christina's death was still preventable.'
The report concluded the ambulance services response that night was marked by an 'excessive and unacceptable' delay.
Lackmann was born in Mona Vale, New South Wales, and grew up with her parents and two brothers.
In March, fitness enthusiast Katie Donnell, 28, died from a caffeine overdose, which her grieving mother attributed to excessive energy drink consumption.
A similar case occurred in 2018, when Australian musician Lachlan Foote, 21, died after mixing a teaspoon of caffeine powder into a protein shake.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

The Independent

33 minutes ago

• The Independent

Mounjaro weight loss jab: All you need to know

GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service begins its mass rollout. Some 220,000 people with the 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly, through the NHS over the next three years. Here the PA news agency takes a look at the drug and the rollout. – How does tirzepatide work? Tirzepatide, or Mounjaro, is an antidiabetic drug which lowers blood sugar levels and slows down how quickly food is digested. It makes you feel fuller for longer and therefore less hungry. If the jab is recommended by a healthcare professional, those using it will need to eat a balanced, reduced-calorie diet and to exercise regularly while taking it, according to the NHS website. – Who might be eligible for the drug? In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of more than 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. It was previously only accessible to patients through a special weight loss service, to severely obese people who also suffer from a range of other health problems. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. – How would it be administered? The drug is usually delivered through a self-administered weekly injection which a doctor or nurse will show patients how to use, the NHS website says. – Who cannot take tirzepatide? Mounjaro is not recommended for those who are pregnant or planning to get pregnant, breastfeeding or have certain health conditions, according to the NHS. For those taking the contraceptive pill and using tirzepatide, the NHS recommends using an additional method of contraception, such as a condom, for the first four weeks of treatment and for four weeks after each dose increase as the contraceptive pill may not be absorbed by the body during this time. – What are the potential side effects? Potential side effects of tirzepatide include nausea, vomiting, diarrhoea and constipation, according to the National Institute for Health and Care Excellence.

Daily Mail​

40 minutes ago

• Daily Mail​

Urgent warning invasive pest will spread across Australia after attempts to eradicate it fail

Biosecurity experts have warned a tiny beetle wreaking havoc in suburban Perth could make its away across the country and devastate Australia's east coast. The polyphagous shot-hole borer has been spreading through metropolitan Perth for the past four years with local authorities at their wit's end on how to deal with it. The invasive beetles bore tunnels through tree trunks causing a fungus to grow inside of it, which it then feeds on. The fungus needs water and nutrients to grow and it disrupts the tree's circulatory system, effectively cutting off its access to water and nutrients, causing it to die. Local authorities have chopped down infected plants and hundreds of trees in an attempt to stop the spread - however the efforts have been futile. The invasive wood boring beetle, about the size of a sesame seed, was first detected in August 2021 in the port city of Fremantle, 20km south of the Perth CBD. Western Australian Agriculture Minister Jackie Jarvis revealed last week the state had given up the fight to eradicate the pest. The state government has decided to focus on trying to slow the spread after a National Management Group meeting last Wednesday determined it was no longer feasible to eradicate shot-hole borer from WA. The decision came after considering the latest scientific data and advice from the country's chief plant health managers and leading plant biosecurity experts. A new national management plan would now be finalised. Since the destructive pest was detected it has infested thousands of trees, many in iconic Perth parks including Kings Park. Ms Jarvis said protecting Perth's tree canopy and the valuable horticulture sector remained front and centre for WA as the national biosecurity response moved into a management phase. 'We will continue to look for alternative solutions by supporting local scientists to undertake more research under WA conditions,' she said. Exactly how the beetle arrived from its native South East Asia remained a mystery, but it has already established infestations in California, Florida, Texas, South Africa, Israel, Sri Lanka, Vietnam, India, Mexico and Thailand. Despite its global devastation and significant widespread scientific research a cure remained elusive. Part of the problem is the beetles are tiny (2–4mm) and their hidden, tunnel-based life makes them hard to treat chemically. And the fact it attacks nearly 700 known tree species including avocadoes, maples, willows, native gum trees and oaks, further complicated tracking and containment. Trials of plastic wraps had largely failed with the only current intervention to cut down and chip infected trees. The Invasive Species Council has warned the decision to end efforts to eradicate the polyphagous shot-hole borer in WA could put the rest of the country at risk. Council policy director Carol Booth said if the beetle made it east, Sydney's lush urban canopy, already under pressure from development, could face mass dieback, hotter streets and the loss of habitat for fauna. 'This is tragic news not just for Western Australia, but potentially for native trees, towns and cities, and the horticultural industry across the entire country,' she said. 'Fifteen native tree species in WA have already been identified as highly or very highly susceptible to the polyphagous shot-hole borer including iconic species like figs, paperbarks, banksias and eucalypts. 'Another 23 species are moderately susceptible, and that's just in the Perth region. It implies hundreds of native species across the country could be at risk if the borer spreads.' Ms Booth said there was grave concerns about the loss of urban trees, which provided vital habitat, shade, beauty and health benefits in cities and towns. 'The environmental and social toll could be immense,' she said. 'We need to learn from this failure. An independent, transparent review is needed to assess whether more could have been done sooner, whether there were delays, missed early detection opportunities, or gaps in public support. 'This beetle was one of Australia's top biosecurity prevention targets. The regular arrival of harmful new invaders shows our prevention systems are not strong enough.' Australia's forest industries are disappointed the Commonwealth and state governments have given up trying to eradicate the insidious pest. Australian Forest Products Association chief executive Diana Hallam said the likelihood it spread from metropolitan Perth to other parts of the country had increased as a consequence of the decision to move from an eradication to a management strategy. 'The risk this beetle poses to trees in forestry operations, national parks, reserves and even backyards is immense and the cost borne by our industry and other stakeholders, like local councils, to prevent its spread and manage its risk will unfortunately, likely increase,' she said. 'We know in South Africa and California, where the borer has already established itself, the losses and cost of management are in the billions of dollars across local governments, horticulture, forestry and the environment through tree deaths or increased management costs.'

BBC News

an hour ago

• BBC News

Cancer patient given months to live is 'more positive than ever'

In early 2021, while sitting in a parked car and on the phone to an oncologist he had never met, Tim Strugnell was told he had "months not years" left to until that point, since being diagnosed nine years earlier, treatments and hormone drugs had succeeded in keeping the 76-year-old's prostate cancer at pensioner's defiant attitude, he believes, had also played a key part, and this time would be no different, with Mr Strugnell vowing "to fight this thing".Four years later, having taking part in three medical trials, all with varying levels of success, the retired school teacher tells the BBC he feels "more positive than ever". According to the National Institute for Health and Care Research (NIHR), over 79,000 people took part in research funded or backed by the NIHR in the East of England last between 2023 and 2024, more than one million people in England took part in a total of 6,074 studies for an array of conditions, including cancer, heart disease and medical trials do not work for everyone, and while Mr Strugnell says he is now feeling the benefits of taking part, his experience has not been without its setbacks. 'Feeling very low' The lifelong Ipswich Town fan, who taught in Suffolk and Norfolk and now lives in Essex, was thrown his first potential lifeline in the form a new cancer vaccine in opportunity came a year after he had been told his cancer had spread to the lymph nodes in his stomach and was no longer responding to experiencing little to no side effects, Mr Strugnell, then trialled immunotherapy infusion hope is that it would rally his white blood cells together to attack the tumours in his body - but it did not have the desired effect."It stopped working and I got a terrible pain in my stomach, so they sent me back to Colchester Hospital for more chemotherapy and radiotherapy, but that made me violently sick," he said."I lost my appetite and I was feeling very low." But all hope was not weeks of attending an event at the House of Commons to raise awareness about clinical trials, Mr Strugnell was given the chance to try another new with hormone medication which cuts off his testosterone, the large blue tablets strive to shrink the size of a cancer – and they seem to be Mr Strugnell started the treatment his PSA score – a metric which measures how large a patient's prostate cancer is - was for the last six months, it has been between 10 and 17."The lower it is the better, so I am really, really positive about this drug," he said."It's not stopping me from doing anything and I am doing far more than a lot of people my age."My whole life has changed - I have a lot more energy and enthusiasm and I am not thinking 'I don't know how long I've got'."I am more positive now than I ever been." While clinical trials are seen by some as positive, in that they can help advance healthcare, there are also downsides prospective patients must to Cancer Research UK, for example, some patients "may have unexpected or serious side effects" and there can be "some risk an experimental treatment could harm you".But for Mr Strugnell, the risks were worth taking."I suppose I am a Guinea pig but you're thinking 'this might work for me, this might help me, and it cannot get any worse, so I will try it'," he said."I am not doing it for people in the future, I am doing it for me, but if it does help people then that's absolutely fantastic and amazing, because it is giving people hope." 'Go away, I am not going to let you win' With a new found sense of optimism, Mr Strugnell, who still loves performing on stage and writing children's book, is keen to continue to live life to the fullest."I am not going to behave like some 76 year olds I know," he said,"I have this kind of energy about me and my life, so the future holds lots for me."If you keep positive then you and your body can deal with it, but if you give up it will take over."If you have been affected by the issues raised in this story you can visit the BBC Action Line for help and support. Follow Suffolk news on BBC Sounds, Facebook, Instagram and X.